Measles-containing-vaccine second-dose (MCV2) immunization coverage in Singapore
Singapore: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 93.0% in 2025. ▼ Falling
Latest (2025)
93.0%
Change on year
unchanged
World rank
49th
of 194 countries
All-time high
98.0%
in 2000
All-time low
88.0%
in 2016
Years of data
26
2000–2025
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Singapore, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in Singapore stood at 93.0%.
That represents a change of up 3.3% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Singapore peaked at 98.0% in 2000 and was at its lowest, 88.0%, in 2016.
Singapore ranks 49th of 194 countries on this measure, in the top quarter.
The long-run direction has been consistently falling across the 26 years of available data.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Singapore, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 98.0% | — |
| 2001 | 96.0% | -2.0% |
| 2002 | 96.0% | +0.0% |
| 2003 | 96.0% | +0.0% |
| 2004 | 96.0% | +0.0% |
| 2005 | 95.0% | -1.0% |
| 2006 | 96.0% | +1.1% |
| 2007 | 96.0% | +0.0% |
| 2008 | 96.0% | +0.0% |
| 2009 | 96.0% | +0.0% |
| 2010 | 96.0% | +0.0% |
| 2011 | 96.0% | +0.0% |
| 2012 | 95.0% | -1.0% |
| 2013 | 90.0% | -5.3% |
| 2014 | 90.0% | +0.0% |
| 2015 | 90.0% | +0.0% |
| 2016 | 88.0% | -2.2% |
| 2017 | 90.0% | +2.3% |
| 2018 | 91.0% | +1.1% |
| 2019 | 92.0% | +1.1% |
| 2020 | 94.0% | +2.2% |
| 2021 | 93.0% | -1.1% |
| 2022 | 92.0% | -1.1% |
| 2023 | 92.0% | +0.0% |
| 2024 | 93.0% | +1.1% |
| 2025 | 93.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 96.1% | 95.0% | 98.0% | 10 |
| 2010s | 91.8% | 88.0% | 96.0% | 10 |
| 2020s | 92.8% | 92.0% | 94.0% | 6 |
Countries ranked near Singapore
More health data for Singapore
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5225 % change on previous year (2090)
- Heat deaths vs projected death rates 1,924 (2090)
- Un projection of annual infant deaths 13 (2100)
- Population ages 65 and above, female, annual growth rate 5.07 % change on previous year (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per capita 0.0764 units per person (2025)
- Population ages 65 and above, male, annual growth rate 5.66 % change on previous year (2025)
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, male, per capita 0.0657 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Singapore?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Singapore was 93.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Singapore?
- The highest recorded value was 98.0% in 2000.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Singapore?
- The lowest recorded value was 88.0% in 2016.
- How does Singapore rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Singapore ranks 49th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Singapore?
- Over the last ten years it is up 3.3%. The long-run trend across the full record is falling.
- Where does this Singapore data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).